Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
Clinical trial NCT00546572 · COMPLETED
Trial details
- NCT number
- NCT00546572
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2010-07-01
- Enrollment
- 938
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.